IKZF1 and autoimmune disease: Data presented in this report support that Ikzf1 hyperlactylation inhibits IL-2 expression and then promotes TH17 differentiation, providing mechanistic explanation for posttranslational modification–regulated IL-2 expression in autoimmune diseases.